Cargando…
CPT1A Over-Expression Increases Reactive Oxygen Species in the Mitochondria and Promotes Antioxidant Defenses in Prostate Cancer
SIMPLE SUMMARY: Prostate cancer (PCa) is the most common cancer in men and the second highest contributor to cancer deaths. Targeting lipid catabolism enzymes in PCa may offer new avenues for therapeutic approaches. During the last decade, carnitine palmitoyl transferase I (CPT1A) has been identifie...
Autores principales: | Joshi, Molishree, Kim, Jihye, D’Alessandro, Angelo, Monk, Emily, Bruce, Kimberley, Elajaili, Hanan, Nozik-Grayck, Eva, Goodspeed, Andrew, Costello, James C., Schlaepfer, Isabel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709014/ https://www.ncbi.nlm.nih.gov/pubmed/33218188 http://dx.doi.org/10.3390/cancers12113431 |
Ejemplares similares
-
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
por: Joshi, Molishree, et al.
Publicado: (2019) -
SAT-175 (-)-Epicatechin Modulates Cellular Signaling and Mitochondrial Redox in Endothelium
por: Johnston, Aspen, et al.
Publicado: (2019) -
(–)-Epicatechin Modulates Mitochondrial Redox in Vascular Cell Models of Oxidative Stress
por: Keller, Amy, et al.
Publicado: (2020) -
OR34-4 ATF3 Is A Converging Point For AR Signaling And Fatty Acid Oxidation In Prostate Cancer
por: Joshi, Molishree, et al.
Publicado: (2019) -
DIPG-61. Preclinical efficacy of combined radiotherapy with venetoclax treatment in targeting diffuse midline gliomas
por: Madhavan, Krishna, et al.
Publicado: (2022)